Skip to content

Blue poo project: Highlighting the interplay between neuropathic pain medications, autonomic neuropathy, and the GI passage

Blue poo project: Highlighting the interplay between neuropathic pain medications, autonomic neuropathy, and the GI passage - Blue poo project

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00031885
Enrollment
50
Registered
2023-05-22
Start date
2023-07-14
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G62.88

Interventions

Group 1: Patients with idiopathic small fiber neuropathy 1. study visit (2-3h): patient history incl. PainDETECT pain questionnaire, Beck's Depression Inventory, Montgomery Asberg Depression Scale, D

Sponsors

Klinik für Neurologie Universitätsklinikum RWTH Aachen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Clinically confirmed small fiber neuropathy 2. No underlying acquired origin of nerve damage 3. Male or female aged = 18 years 4. Written informed consent prior to project participation 5. The subject is willing and able to follow the procedures outlined in the project plan

Exclusion criteria

Exclusion criteria: 1. Acquired cause of neuropathy (Diabetes mellitus, alcohol consumption, kidney insufficiency, vitamin deficiency) 2. Clinical criteria for the diagnosis of small fiber neuropathy not fulfilled 3. Patient has been committed to an institution by legal or regulatory order 4. Participation in a parallel interventional clinical trial 5. The subject is mentally or legally incapacitated

Design outcomes

Primary

MeasureTime frame
To quantify gastrointestinal transit times in patients diagnosed with small fiber neuropathy. Patients eat a specifically prepared muffin containing a non-toxic, non-absorbable blue dye that will be tracked for one month. For that, we will use an app as a patient diary (poop app), which will help to document the presence of blue colour in their stools.

Secondary

MeasureTime frame
• To correlate GI transit times with subjective symptoms (patient history) • To correlate GI transit times with neuropathic pain and medication history (anamnesis, PainDETECT pain questionnaire) • To investigate drug bioavailability and biomarker profiles from breath air in correlation with GI transit times (breath gas analysis via Proton-Transfer-Reaction Mass Spectrometry, blood levels pain medication)

Countries

Germany

Contacts

Public ContactGreta Peschke

Klinik für Neurologie Universitätsklinikum RWTH Aachen

gpeschke@ukaachen.de0241-8080880

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026